Long‐Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1‐Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy

Documenti analoghi

• Adverse Impact of Pre‐Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation
  di: Yukiko Misaki, et al.
  Pubblicazione: (2025)
• Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First Transplantation
  di: Kazuki Yoshimura, et al.
  Pubblicazione: (2025)
• Increased Non‐Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan‐Based Regimen
  di: Akihito Shinohara, et al.
  Pubblicazione: (2025)
• Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
  di: Shohei Mizuno, et al.
  Pubblicazione: (2024)
• Effect of Early Administration of Anti‐MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation
  di: Anna Akaogi, et al.
  Pubblicazione: (2026)